These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Possible thromboxane A2 mediated effect of angiotensin II in the rabbit isolated perfused kidney.
    Author: Ercan ZS, Sindel S, Türker R.
    Journal: Arch Int Physiol Biochim Biophys; 1991 Dec; 99(6):397-400. PubMed ID: 1725738.
    Abstract:
    Angiotensin II (A II) when given through the renal artery of the rabbit isolated perfused kidney elicited a concentration-dependent increase in perfusion pressure (PP) and urine flow (UF). Noradrenaline (NA) produced similar effect in PP but slightly not significantly increased UF. Addition of UK 38,485, a thromboxane A2 (TXA2)-synthetase inhibitor, to the bathing medium at the concentration of 10(-7) M caused a significant decrease in the pressor effect of A II but significantly enhanced UF. BM 13,177, a TXA2-receptor blocker, in the bathing medium (10(-6) M) produced identical effect in both PP and UF. The responses to NA were not significantly altered by both compounds. A II-induced enhancement of UF in presence of BM 13,177 was significantly lower than that obtained in presence of UK 38,485. These results were taken as an evidence that A II may increase the production of TXA2 in kidney probably originated from vascular bed or tubuli and part of the pressor effect of the peptide is due to this metabolite of arachidonic acid. Enhancement of UF following UK 38,485 is probably due to the shift of the synthesis toward E series of PGs. In addition this effect seems to be specific for A II since no such effect was seen with NA.
    [Abstract] [Full Text] [Related] [New Search]